David Netzer Consulting Eng’r LLC v. Shell Oil Co., No.2015-2086 (Fed. Cir. May 27, 2016).
In re Arunachalam, No.2016-1560 (Fed. Cir. May 27, 2016).
Friday, May 27, 2016
Thursday, May 26, 2016
New Federal Circuit Opinions - May 26, 2016
Profectus Tech. LLC v. Huawei Techs. Co., Nos. 2015-1016, 2015-1018, 2015-1019 (Fed. Cir. May 26, 2016).
Wednesday, May 25, 2016
New Federal Circuit Opinions - May 25, 2016
In re Aqua Prods., Inc., No. 2015-1177 (Fed. Cir. May 25, 2016).
Friday, May 20, 2016
Reassessing How to Draft “Preferred Embodiments” in Patent Applications
Holding
In Howmedica OsteonicsCorp. v. Zimmer, Inc., Nos. 2015-1232, -1234, -1239,
slip op. at 15-16 (Fed. Cir. May 12, 2016), the Federal Circuit held that
introductory clauses such as “In the preferred embodiment” may “limit only the
sentences in which they are located” and not the succeeding sentences in the
same paragraph.
Key Facts and Observations
The dispute involves the “essentially midway”
construction in U.S. Patent No. 6,475,243 (“’243 patent”) concerning a socket
assembly used in prosthetic hip implants.
The patent owner argued that the “essentially
midway” language in the written description concerns a preferred embodiment and
cannot be used to limit the claims. Slip op., at 15. Specifically, the patent owner reasoned that introductory
clauses such as “In the preferred embodiment” apply not only to the sentences
in which they are located, but also to the succeeding sentences in the same
paragraph. Id.
The Federal Circuit disagreed, finding that “context
reveals that such introductory clauses limit only the sentences in which they
are located in this case.” Id. at
15-16. The Federal Circuit also gave little weight to the generalized
disclaimers such as “The invention will be understood more fully . . . in the following
detailed description of preferred embodiments of the invention” and “It is to
be understood that the above detailed description of preferred embodiments of
the invention is provided by way of example only.” Id. at 16.
A closer review of the relevant language in the ’243
patent reveals that the Federal Circuit’s holding
on “preferred embodiments”
may not be as far-reaching as it appears. Specifically, the “preferred embodiments”
language appears in the middle of a paragraph in the ’243 patent. See, e.g., ’243 patent, col. 6, l. 64 –
col. 7, l. 17. Therefore, the Federal Circuit found that “context reveals
that such introductory clauses limit only the sentences in which they are
located in this case.” Slip op. at
15-16 (emphasis added).
Practice Tips
In light of this opinion, when drafting preferred
embodiments, patent attorneys should consider (1) using the “In a preferred
embodiment” language in the beginning of a paragraph, and/or (2) adding another
generalized disclaimer such as “The discussion of the preferred embodiments herein
shall not be construed to limit only the sentences in which introductory
clauses such as ‘In a preferred embodiment’ are located.”
Tuesday, May 17, 2016
New Federal Circuit Opinions - May 17, 2016
In re TLI Commc'n LLC Patent Litig., Nos. 2015-1372, -1376, -1377, -1378, -1379, -1382, -1383, -1384, -1385, -1417, -1419, -1421 (Fed. Cir. May 17, 2016).
Diamond Coating Techs., LLC v. Hyundai Motor Am., Nos. 2015-1844, 2015-1861 (Fed. Cir. May 17, 2016).
Diamond Coating Techs., LLC v. Hyundai Motor Am., Nos. 2015-1844, 2015-1861 (Fed. Cir. May 17, 2016).
Monday, May 16, 2016
New Federal Circuit Opinions - May 16, 2016
Intendis GmbH v. Glenmark Pharm. Ltd., No. 2015-1902 (Fed. Cir. May 16, 2016).
Friday, May 13, 2016
New Federal Circuit Opinions - May 13, 2016
Merck & Cie v. Watson Labs., Inc., Nos. 2015-2063, 2015-2064 (Fed. Cir. May 13, 2016).
Thursday, May 12, 2016
New Federal Circuit Opinions - May 12, 2016
Howmedica Osteonics Corp. v. Zimmer, Inc., Nos. 2015-1232, -1234, -1239 (Fed. Cir. May 12, 2016).
Enfish, LLC v. Microsoft Corp., No. 2015-1244 (Fed. Cir. May 12, 2016).
Enfish, LLC v. Microsoft Corp., No. 2015-1244 (Fed. Cir. May 12, 2016).
Monday, May 9, 2016
New Federal Circuit Opinions - May 9, 2016
Intelligent Bio-Sys., Inc. v. Illumina Cambridge Ltd., No. 2015-1693 (Fed. Cir. May 9, 2016).
Subscribe to:
Posts (Atom)